We are live on ! Find out more
ACA

Atlas Capital Advisors Portfolio holdings

AUM $875M
This Fund
S&P 500
This Quarter Est. Return
+2.23%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$770M
AUM Growth
+$130M
Cap. Flow
+$122M
Cap. Flow %
15.79%
Top 10 Hldgs %
26%
Holding
984
New
94
Increased
180
Reduced
306
Closed
93

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$45.5M
2
MSFT icon
Microsoft
MSFT
+$17M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.08M
4
AMZN icon
Amazon
AMZN
+$7.25M
5
PLMR icon
Palomar
PLMR
+$7.01M

Sector Composition

Rank Sector Weight
1 Technology 12.15%
2 Consumer Staples 7.79%
3 Financials 6.32%
4 Healthcare 4.92%
5 Consumer Discretionary 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRUS icon
226
Cirrus Logic
CRUS
$6.26B
$448K 0.06%
3,510
+3,108
+773% +$326K
ZBH icon
227
Zimmer Biomet
ZBH
$18.4B
$448K 0.06%
4,126
+3,960
+2,386% +$467K
PBR.A icon
228
Petrobras Class A
PBR.A
$103B
$446K 0.06%
32,719
-1,480
-4% -$22K
BX icon
229
Blackstone
BX
$110B
$446K 0.06%
3,600
-11,199
-76% -$1.38M
CB icon
230
Chubb
CB
$135B
$443K 0.06%
1,737
DKS icon
231
Dick's Sporting Goods
DKS
$18.7B
$439K 0.06%
2,044
-539
-21% -$112K
RSPH icon
232
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$784M
$437K 0.06%
14,563
+1
+0% +$30
NOC icon
233
Northrop Grumman
NOC
$81.2B
$436K 0.06%
999
-152
-13% -$69.4K
WAB icon
234
Wabtec
WAB
$49.3B
$435K 0.06%
2,750
PCG icon
235
PG&E
PCG
$38.5B
$432K 0.06%
24,722
+6,019
+32% +$106K
CNM icon
236
Core & Main
CNM
$8.71B
$428K 0.06%
8,741
-7,172
-45% -$398K
SMFG icon
237
Sumitomo Mitsui Financial
SMFG
$164B
$424K 0.06%
31,622
+4,233
+15% +$51.3K
CEG icon
238
Constellation Energy
CEG
$95.6B
$422K 0.05%
2,105
-65
-3% -$13.3K
STLD icon
239
Steel Dynamics
STLD
$37.6B
$419K 0.05%
3,232
-522
-14% -$69.7K
EQH icon
240
Equitable Holdings
EQH
$14.1B
$418K 0.05%
+10,220
New +$400K
FN icon
241
Fabrinet
FN
$20.1B
$416K 0.05%
1,701
-57
-3% -$12.1K
TMO icon
242
Thermo Fisher Scientific
TMO
$220B
$413K 0.05%
747
-100
-12% -$57.3K
MRO
243
DELISTED
Marathon Oil Corporation
MRO
$412K 0.05%
14,357
-4,767
-25% -$132K
INGR icon
244
Ingredion
INGR
$6.58B
$411K 0.05%
3,586
+1,451
+68% +$168K
NUE icon
245
Nucor
NUE
$62.1B
$410K 0.05%
2,595
-200
-7% -$34.8K
DEO icon
246
Diageo
DEO
$53.6B
$407K 0.05%
+3,230
New +$445K
AZN icon
247
AstraZeneca
AZN
$250B
$406K 0.05%
2,605
-248
-9% -$37.3K
USFD icon
248
US Foods
USFD
$24B
$406K 0.05%
7,661
-66
-0.9% -$3.47K
IWD icon
249
iShares Russell 1000 Value ETF
IWD
$83.7B
$406K 0.05%
2,325
+1,300
+127% +$227K
NWG icon
250
NatWest
NWG
$76.4B
$404K 0.05%
+50,325
New +$391K

Similar funds

Atlas Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Atlas Capital Advisors held 984 positions worth $770M, up 20% from $640M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Atlas Capital Advisors deployed $122M of net new capital in Q2 2024, opening 94 new positions and adding to 180 existing holdings. Its largest new stake was Prudential Financial: 8,398 shares worth $984K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.6% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was iShares MSCI Intl Momentum Factor ETF, an estimated $3.1M trimmed.

  • Atlas Capital Advisors's largest Q2 2024 buy was Prudential Financial: 8,398 shares worth $984K.
  • Atlas Capital Advisors added most to Procter & Gamble in Q2 2024, an estimated $45.5M increase.
  • Atlas Capital Advisors's biggest Q2 2024 reduction was iShares MSCI Intl Momentum Factor ETF, cutting an estimated $3.1M.
  • Atlas Capital Advisors fully exited Affirm in Q2 2024, selling an estimated $510K.
  • Atlas Capital Advisors's ten largest holdings make up 26% of its $770M portfolio in Q2 2024.
  • Atlas Capital Advisors opened 94 new positions and closed 93 in Q2 2024.
  • Atlas Capital Advisors's portfolio value rose 20% quarter-over-quarter to $770M.

Based on Atlas Capital Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.